453 related articles for article (PubMed ID: 26258417)
1. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.
Boscolo E; Limaye N; Huang L; Kang KT; Soblet J; Uebelhoer M; Mendola A; Natynki M; Seront E; Dupont S; Hammer J; Legrand C; Brugnara C; Eklund L; Vikkula M; Bischoff J; Boon LM
J Clin Invest; 2015 Sep; 125(9):3491-504. PubMed ID: 26258417
[TBL] [Abstract][Full Text] [Related]
2. Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation.
Li X; Cai Y; Goines J; Pastura P; Brichta L; Lane A; Le Cras TD; Boscolo E
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):496-512. PubMed ID: 30626204
[TBL] [Abstract][Full Text] [Related]
3. AKT/FOXO1 axis links cross-talking of endothelial cell and pericyte in TIE2-mutated venous malformations.
Si Y; Huang J; Li X; Fu Y; Xu R; Du Y; Cheng J; Jiang H
Cell Commun Signal; 2020 Aug; 18(1):139. PubMed ID: 32867785
[TBL] [Abstract][Full Text] [Related]
4. A xenograft model for venous malformation.
Goines J; Li X; Cai Y; Mobberley-Schuman P; Metcalf M; Fishman SJ; Adams DM; Hammill AM; Boscolo E
Angiogenesis; 2018 Nov; 21(4):725-735. PubMed ID: 29786783
[TBL] [Abstract][Full Text] [Related]
5. A Xenograft Model for Venous Malformation.
Goines J; Boscolo E
Methods Mol Biol; 2021; 2206():179-192. PubMed ID: 32754818
[TBL] [Abstract][Full Text] [Related]
6. Constitutive Active Mutant TIE2 Induces Enlarged Vascular Lumen Formation with Loss of Apico-basal Polarity and Pericyte Recruitment.
Cai Y; Schrenk S; Goines J; Davis GE; Boscolo E
Sci Rep; 2019 Aug; 9(1):12352. PubMed ID: 31451744
[TBL] [Abstract][Full Text] [Related]
7. Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
Du Z; Zheng J; Zhang Z; Wang Y
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):740-748. PubMed ID: 28818232
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations.
Morris PN; Dunmore BJ; Tadros A; Marchuk DA; Darland DC; D'Amore PA; Brindle NP
J Mol Med (Berl); 2005 Jan; 83(1):58-63. PubMed ID: 15526080
[TBL] [Abstract][Full Text] [Related]
9. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
Huang YH; Wu MP; Pan SC; Su WC; Chen YW; Wu LW
Angiogenesis; 2013 Jan; 16(1):207-22. PubMed ID: 23086340
[TBL] [Abstract][Full Text] [Related]
10. Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression.
Hu HT; Huang YH; Chang YA; Lee CK; Jiang MJ; Wu LW
J Invest Dermatol; 2008 Sep; 128(9):2325-33. PubMed ID: 18401423
[TBL] [Abstract][Full Text] [Related]
11. Classification and Tie2 mutations in spinal and soft tissue vascular anomalies.
Zhou M; Jiang R; Zhao G; Wang L; Wang H; Li W; Li Y; Du X; Bai J
Gene; 2015 Oct; 571(1):91-6. PubMed ID: 26115772
[TBL] [Abstract][Full Text] [Related]
12. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.
Uebelhoer M; Nätynki M; Kangas J; Mendola A; Nguyen HL; Soblet J; Godfraind C; Boon LM; Eklund L; Limaye N; Vikkula M
Hum Mol Genet; 2013 Sep; 22(17):3438-48. PubMed ID: 23633549
[TBL] [Abstract][Full Text] [Related]
13. Development of Molecular Therapies for Venous Malformations.
Kangas J; Nätynki M; Eklund L
Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():6-19. PubMed ID: 29668117
[TBL] [Abstract][Full Text] [Related]
14. Somatic Activating PIK3CA Mutations Cause Venous Malformation.
Limaye N; Kangas J; Mendola A; Godfraind C; Schlögel MJ; Helaers R; Eklund L; Boon LM; Vikkula M
Am J Hum Genet; 2015 Dec; 97(6):914-21. PubMed ID: 26637981
[TBL] [Abstract][Full Text] [Related]
15. Common and specific effects of TIE2 mutations causing venous malformations.
Nätynki M; Kangas J; Miinalainen I; Sormunen R; Pietilä R; Soblet J; Boon LM; Vikkula M; Limaye N; Eklund L
Hum Mol Genet; 2015 Nov; 24(22):6374-89. PubMed ID: 26319232
[TBL] [Abstract][Full Text] [Related]
16. Mutant Tie2 causing venous malformation signals through Shc.
Morris PN; Dunmore BJ; Brindle NP
Biochem Biophys Res Commun; 2006 Jul; 346(1):335-8. PubMed ID: 16756945
[TBL] [Abstract][Full Text] [Related]
17. Association study between of Tie2/angiopoietin-2 and VEGF/KDR pathway gene polymorphisms and vascular malformations.
Zheng Q; Du J; Zhang Z; Xu J; Fu L; Cao Y; Huang X; Guo L
Gene; 2013 Jul; 523(2):195-8. PubMed ID: 23566851
[TBL] [Abstract][Full Text] [Related]
18. Somatic TEK variant with intraarticular venous malformation and knee hemarthrosis treated with rapamycin.
Adham S; Revencu N; Mestre S; Nou-Howaldt M; Vernhet-Kovacsik H; Quéré I
Mol Genet Genomic Med; 2022 Jun; 10(6):e1931. PubMed ID: 35426265
[TBL] [Abstract][Full Text] [Related]
19. Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.
Castillo SD; Tzouanacou E; Zaw-Thin M; Berenjeno IM; Parker VE; Chivite I; Milà-Guasch M; Pearce W; Solomon I; Angulo-Urarte A; Figueiredo AM; Dewhurst RE; Knox RG; Clark GR; Scudamore CL; Badar A; Kalber TL; Foster J; Stuckey DJ; David AL; Phillips WA; Lythgoe MF; Wilson V; Semple RK; Sebire NJ; Kinsler VA; Graupera M; Vanhaesebroeck B
Sci Transl Med; 2016 Mar; 8(332):332ra43. PubMed ID: 27030595
[TBL] [Abstract][Full Text] [Related]
20. Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β.
Chen G; Ren JG; Zhang W; Sun YF; Wang FQ; Li RF; Zhang J; Zhao YF
Sci Rep; 2014 Jun; 4():5457. PubMed ID: 24966004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
